Literature DB >> 1251235

Methylphenidate: a review.

L Oettinger, L V Majovski.   

Abstract

Methylphenidate is a useful, proven method for the effective treatment of minimal brain dysfunction (MBD). Dosage should be titrated individually for each patient, and it is best to start with small doses given at least 15 to 30 minutes before meals. Toxicity, side effects, and drug abuse are not major problems. Unfortunately it is not yet possible to determine in advance who will and will not benefit from drug therapy; not all patients do. Treatment of MBD requires a multidisciplinary approach, for no one discipline alone can satisfactorily solve the problems involved. We believe, however, that medicine is the primary therapy in most instances.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1251235     DOI: 10.1097/00007611-197602000-00010

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  3 in total

Review 1.  Pharmacokinetics and clinical effectiveness of methylphenidate.

Authors:  H C Kimko; J T Cross; D R Abernethy
Journal:  Clin Pharmacokinet       Date:  1999-12       Impact factor: 6.447

2.  Effects of food on the pharmacokinetics of methylphenidate.

Authors:  K K Midha; G McKay; M J Rawson; E D Korchinski; J W Hubbard
Journal:  Pharm Res       Date:  2001-08       Impact factor: 4.200

Review 3.  Pharmacokinetic considerations in the treatment of attention-deficit hyperactivity disorder with methylphenidate.

Authors:  Mark L Wolraich; Melissa A Doffing
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.